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Through the expression of the accessory gene regulator quorum sensing cascade,
Staphylococcus aureus is able to produce an extensive array of enzymes, hemolysins
and immunomodulators essential to its ability to spread through the host tissues and
cause disease. Many have argued for the discovery and development of quorum sensing
inhibitors (QSIs) to augment existing antibiotics as adjuvant therapies. Here, we discuss
the state-of-the-art tools that can be used to conduct screens for the identiﬁcation of
such QSIs. Examples include ﬂuorescent reporters, MS-detection of autoinducing peptide
production, agar plate methods for detection of hemolysins and lipase, High performance
liquid chromatography-detection of hemolysins from supernatants, and cell-toxicity assays
for detecting damage (or relief thereof) against human keratinocyte cells. In addition to
providing a description of these various approaches, we also discuss their amenability to
low-, medium-, and high-throughput screening efforts for the identiﬁcation of novel QSIs.
Keywords: accessory gene regulator, Staphylococcus aureus, auto inducing peptides, drug discovery, toxins,
quorum sensing, adjuvant therapy, quorum sensing inhibitor
INTRODUCTION
Staphylococcus aureus is an opportunistic pathogen that is the
causative agent of numerous acute and chronic infections (Skov
et al., 2012; Uhlemann et al., 2014). The prevalence of these infec-
tions has increased due to higher rates of colonization, immuno-
suppressive conditions, greater use of surgical implants, and dra-
matic increases in antibiotic resistance. More recently, methicillin
resistant Staphylococcus aureus (MRSA) strains expanded from
healthcare settings and began infecting otherwise healthy individ-
uals in the community. These strains were coined “community-
associated” MRSA (CA-MRSA) for their new properties and have
become the most recent epidemic wave of resistance in S. aureus
(Chambers and Deleo, 2009; DeLeo and Chambers, 2009). Out-
breaks of CA-MRSAhave spreadworldwidewith remarkable speed
and have affected otherwise healthy individuals (Hidron et al.,
2009; Yamamoto et al., 2010). Indeed, CA-MRSA infections confer
a substantial clinical and economic burden, with total costs in the
United States (US) estimated at over $15 billion US dollars per
year (Lee et al., 2013). Given our knowledge of how quickly drug
resistance spreads in S. aureus, it is apparent that we are rapidly
exhausting current treatment options.
The hypervirulent nature of CA-MRSA is due to its active cell–
cell communication pathway, or quorum sensing system, which
controls expression of an extensive array of enzymes, hemolysins,
and immunomodulators that are essential to its ability to spread
through tissues and cause disease (Novick, 2003). These viru-
lence factors serve a wide scope of purposes in the infection
process, including disruption of the epithelial barrier, inhibition
of opsonization by antibody and complement, neutrophil cytol-
ysis, interference with neutrophil chemotaxis, and inactivation
of antimicrobial peptides (Tsuji et al., 2007; Spaan et al., 2013;
Foster et al., 2014; Otto, 2014). The expression of all of these inva-
sive factors is controlled by cell-density quorum sensing using the
autoinducing peptide (AIP) molecule. Like other quorum sensing
signals, AIP accumulates outside the cell until it reaches a critical
concentration and then binds to a surface receptor called AgrC,
initiating a regulatory cascade (Figure 1). Since AIP controls the
expression of accessory factors for S. aureus, this regulatory sys-
tem has been named the accessory gene regulator (agr), and the
majority of the proteins necessary for this quorum sensing system
to function are encoded in the agr chromosomal locus (Novick,
2003; Thoendel et al., 2010). The use of small molecule inhibitors
to “ﬂip the agr switch” off and quench this communication sys-
tem to attenuate pathogenicity and virulence lies at the core of the
anti-virulence approach (Zhu and Kaufmann, 2013).
Despite recognition of the important role of agr regulation in S.
aureus pathogenesis, to date, no quorum sensing inhibitor (QSI)
candidates have made it to the clinic (Zhu and Kaufmann, 2013).
However, efforts dedicated to the discovery of small molecule
inhibitors of this system are currently underway in many labs, and
have already resulted in the discovery of several promising leads
(Table 1). These QSIs were identiﬁed through screens of synthetic
compounds and natural products of various origins (i.e., fun-
gal, botanical, microbial, and marine sources), see for example:
(Quave et al., 2011; Murray et al., 2014; Nielsen et al., 2014; Sully
et al., 2014). In this article, we aim to review the various tools being
used in these ongoing efforts to identify novel inhibitors of the S.
aureus agr system.
STRAINS AND MUTANT CONTROLS
One of the most important aspects of investigating the agr system
is the use of appropriate strains and controls. The USA300 (agr
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FIGURE 1 | Schematic of the Staphylococcus aureus accessory gene
regulatory (agr ) system.The agr locus is known to contain two divergent
transcripts named RNAII and RNAIII. The RNAII transcript is an operon of four
genes, agrBDCA, that encode factors required to synthesize AIP and activate
the regulatory cascade. Brieﬂy, AgrD is the precursor peptide of AIP, AgrB is a
membrane protease involved in generating AIP, AgrC is a histidine kinase that
is activated by binding AIP, and AgrA is a response regulator that induces
transcription of RNAII and RNAIII through the P2 and P3 promoters,
respectively. AgrA also directly promotes PSM production. The RNAIII
transcript yields a regulatory RNA molecule that acts as the primary effector
of the agr system by up-regulating extracellular virulence factors and
down-regulating cell surface proteins (Novick et al., 1993).
Table 1 | Examples of reported inhibitors of the Staphylococcus
aureus agr system.
Process or Agent Mechanism Reference
AIP analogs (many types) AgrC antagonists Reviewed in Gordon
et al. (2013)
cyclo(L-Tyr-L-Pro) and
cyclo(L-Phe-L-Pro)
Unknown; perhaps
AgrC antagonist
Li et al. (2011)
Solonamide A and B AgrC antagonists Nielsen et al. (2014)
Ambuic acid AgrB inhibitor Nakayama et al.
(2009)
Savirin AgrA inhibitor Sully et al. (2014)
Polyhydroxyanthraquinones Unknown Figueroa et al. (2014)
Type I) strains have a very robust agr system and produce con-
sistently high levels of RNAIII (Li et al., 2009). Considering these
strains are clinically relevant, the USA300s are excellent testing
and screening strains for QSIs due to the large dynamic range of
quorum sensing function. For conﬁrmation, complete deletions
of the agr system are available in USA300 (Lauderdale et al., 2009,
2010; Pang et al., 2010), and thesemutants can be used to assess the
agr selectivity of an inhibiting agent, as was done recently with the
compound savirin (Sully et al., 2014). In testing the therapeutic
efﬁcacy of a QSI, the agr mutants are also important controls in
animal models of infection to determine the importance of quo-
rum sensing during host interactions (Thoendel et al., 2010). As
a small-molecule control, the competing AIP-II or AIP-III signal
serves as a low nanomolar inhibitor of the AgrC receptor, and
these can be easily synthesized for studies (Mayville et al., 1999).
For other agr Type I strains, older isolates like NCTC8325-4 and
Newman have been used in many pioneering studies on agr func-
tion (Thoendel et al., 2010). While there have been tremendous
advances made in these strains, they do have some limitations,
such as the rsbU deletion in 8325-4 that greatly enhances RNAIII
output (Lauderdale et al., 2009), potentially skewing the interpre-
tation of inhibitor potency. More recently, there has been effort
to ﬁx these issues by repairing chromosomal mutations, with a
goal of having a wild-type strain amenable to laboratory research
(Herbert et al., 2010).
Going beyond the agr Type I strains, the availability of useful
isolates, tools, and knowledge greatly diminishes. Although agr
Type II strains were discovered early (Ji et al., 1997), they have
received sparingly little attention in ongoing studies. The 1963
isolate 502A (often called SA502A or SA502a) has been the ‘go to’
strain for essentially all agr Type II studies. This strain is geneti-
cally tractable and agr reporters are available (Kirchdoerfer et al.,
2011), and more recently the genome has been sequenced (Parker
et al., 2014). However, the focus on 502A is somewhat misplaced
considering recent clinical USA100 isolates are also agr Type II and
represent over 53% of many hospital MRSA collections (Limbago
et al., 2009). Similarly, for agr type III strains, USA400 MW2 has
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become the strain of choice for studies. It is a relevant clinical iso-
late (Baba et al., 2002), has a robust agr system, and agr mutants
and reporters are available (Kirchdoerfer et al., 2011; Olson et al.,
2013), making it an excellent strain for ongoing investigation and
inhibitor testing. The agr type IV system is the rarest in terms of
global distribution of S. aureus isolates (Holtfreter et al., 2007).
Strains with reporters are available (Kirchdoerfer et al., 2011), but
few other tools or mutants have been developed. When using
any of these strains, caution is suggested due to the tendency of
the agr system to mutate (Shopsin et al., 2008). Frequent test-
ing of hemolytic activity and reconstruction of reporters is often
necessary in order to draw accurate conclusions about a QSI
candidate.
THE QSI DETECTOR TOOLBOX
Following a review of the literature on the staphylococcal agr sys-
tem, we have identiﬁed four major groups of in vitro and ex vivo
tools used for assessing agr function: agar plate assays, cell cul-
ture and ex vivo techniques, chromatographic tools and molecular
tools. These assays differ in cost, sensitivity, and amenability to
screening of small molecules for QSI activity (Table 2). For the
purposes of clarity, herewe delineate the characteristics considered
Table 2 | Summary of existing tools for assessing agr function.
Assay Throughputa EEb SMc Referenced
L M H
Agar Plate Assays
CAMP test  Elek and Levy (1950)
β-hemolytic disk assay for δ-hemolysin  Schweizer et al. (2011)
Phospholipase plate assay  Kouker and Jaeger (1987), Laabei et al. (2014)
Agar plate X-GAL test  Nielsen et al. (2010)
Cell culture and ex vivo techniques
Bacterial survival with neutrophils   Schwartz et al. (2009), Pang et al. (2010),
White et al. (2014)
Human neutrophil lysis test    Nielsen et al. (2014)
Human keratinocyte cell lysis test    Cech et al. (2012)
Rabbit erythrocyte lysis test    Pang et al. (2010)
Virulence expression on reconstituted human epithelia   Paniagua-Contreras et al. (2014)
Chromatography tools
HPLC quantiﬁcation of δ-hemolysin     Otto and Gotz (2000), Quave et al. (2011)
LC-MS detection of δ-hemolysin   Somerville et al. (2003)
MALDI-TOF/TOF MS detection of δ-hemolysin   Gagnaire et al. (2012)
HPLC quantiﬁcation of PSM-α    Chua et al. (2014)
IMS and MALDI-MS/MS characterization of metabolic products
and PSMs
   Gonzalez et al. (2012)
Quantiﬁcation of extracellular AIPs by UHPLC/MS    Junio et al. (2013), Roux et al. (2014)
Molecular techniques
Transcriptional analyses by Northern blotting    Gagnaire et al. (2012), Nielsen et al. (2014)
qRT-PCR   Park et al. (2007)
agr::P3 driven GFP reporter assay     Murray et al. (2014), Sully et al. (2014)
agr ::P3 driven lux reporter assay     Subrt et al. (2011), Figueroa et al. (2014)
P3-blaZ reporter    Nielsen et al. (2014)
AIP ﬂuorescent reporter competition assay   Kavanaugh et al. (2007), Malone et al. (2007)
Vesicle lysis test   Laabei et al. (2014)
aTesting throughput: Assay is amenable to the following throughput testing. L, low throughput testing, amenable to a small number of samples. M,medium throughput
screening, amenable to 96-well plate assays and not requiring robotic liquid handling systems. H, high throughput screening, amenable to large samples, such as
96-well or 384-well microtiter plates with the assistance of robotics.
bEE: Requires the use of expensive equipment or core services, such as microplate readers, HPLC, mass spectrometer, and etc.
cSM: Adapted for testing small molecule inhibitors of the agr system.
dReferences: Select references are included and this does not represent the full body of literature for each assay.
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during our categorization of techniques as being low-, medium-,
or high- throughput:
• Low throughput refers to techniques that require heavymanual
personnel involvement, with little to no robotics. These are best
suited to small-scale investigation of no more than a few drug
candidates at a time and aremost appropriate for the secondary
or tertiary QSI lead validation stage in the discovery process.
• Medium throughput refers to those techniques which are
amenable to screening hundreds of compounds. These meth-
ods are often conducted in micro-volume assays (e.g., with
96-well plates), require personnel for sample setup and pro-
cessing, and incorporate some degree of automation (e.g.,
microtiter plate readers, autosamplers, etc.).
• High throughput refers to the heavy integration of automa-
tion into the experimental and computational approaches
employed. High throughput screening (HTS) efforts can be
used to rapidly screen large numbers (1000s to 100s of 1000s)
of test compounds at rates that are impossible to duplicate with
low- and medium- throughput approaches. Personnel involve-
ment in liquid handling is more limited, and robotics systems
are employed to reduce manual labor. Prior to implementation
of HTS, it is recommended to use smaller pilot screens to cal-
culate the Z-factor (also known as Z-prime or Z′) to determine
the suitability of an assay to HTS applications (Zhang et al.,
1999).
AGAR PLATE ASSAYS
Blood agar plate assays
A simple method for assessing agr activity is to test the hemolytic
activity of δ-hemolysin by streaking culture on a blood agar plate
in combination with an intersecting streak of a β-hemolytic pos-
itive strain in the CAMP assay (Elek and Levy, 1950). While this
inexpensive test can be used to detect agr activity, it has not yet
been adapted for small molecule screening efforts.
Another useful assay for detecting hemolytic activity of agr
translational products involves streaking strains on a TSA plate
with 5% sheep blood, starting at the center of the blood agar
plate which contains a β-hemolysin disk and moving outward
(Schweizer et al., 2011). δ-hemolysin is detected through visual-
ization of a zone of clearance created by synergistic activity with
β-hemolysin near the center of the plate. While not very amenable
to screening many QSIs (only one candidate at a time would be
incorporated into the media of the plate), this could be easily
adapted for examination of a QSI candidate against up to six
strains at a time or as a means of secondary conﬁrmation of QSI
activity following HTS. Expected results would include zones of
clearance along the streak of the agar control plate, and lack of
zone formation along the growth streaks found on the agar plate
containing the QSI candidate. Thus, it could be a simple useful
test for assessing quenching activity against the four agr types on
a single agar plate.
Phospholipase plate assay
In addition to the production of toxins, S. aureus also produces
a number of enzymes, some of which exhibit lipolytic activity as
(phospho)lipases (Laabei et al., 2014). A new version of the lipase
plate assay involves a modiﬁcation of the original method (Kouker
and Jaeger, 1987) that incorporates olive oil (1%) and rhodamine
B (0.001%) into the substrate added to the agar medium (Laabei
et al., 2014). Holes are then punched into the agar and supernatant
is added, the plate incubated, irradiated with UV light, and images
captured for analysis. An orange halo emerging around the super-
natant indicates the presence of lipase (Figure 2). Treatment of
S. aureus with a successful QSI will not yield the halo zone in the
agar dish, indicating the lack of lipolytic enzymes present in the
supernatant.
Agar plate X-GAL test
Staphylococcus aureus strains with integrated hla::lacZ and
spa::lacZ reporters have been used to screen for compounds
with agr QSI properties (Nielsen et al., 2010). The hla gene
encodes for α-toxin and the spa gene encodes for Protein A.
As a chromosomal reporter, the lacZ gene encodes for the
enzyme β-galactosidase that is readily detectable through col-
orimetric assays. Tryptic soy agar plates are made containing a
diluted overnight culture of a reporter strain, the appropriate
antibiotic to maintain the reporter, and X-GAL (5-bromo-4-
chloro-3-indolyl-β-D-galactopyranoside) as a reagent to detect
β-galactosidase activity. Following incubation, the plates contain-
ing hla::lacZ will become intensely blue due to high hla expression
and thus production of β-galactosidase enzyme, while plates with
spa::lacZ will become very light blue. Positive hits can be visu-
alized by blue/white screening of the rings surrounding the hole
punches containing putative QSIs. The intent of this approach is
that QSIs added to the plate will prevent expression of hla, lead-
ing to white rings on the X-GAL plates. Simultaneously, a QSI
will induce Protein A expression, leading to a blue ring with the
spa::lacZ reporter Figure 3. Using the two reporters in parallel
makes the assay more robust and has led to the successful identiﬁ-
cation of QSIs. A major advantage of this assay is its simplicity and
low expense for screening both individual compounds and more
complex natural product extracts. However, the hla reporter is also
an indicator of SaeR/S regulatory expression and its interpretation
must be considered carefully; see more on this in the section on
qRT-PCR.
FIGURE 2 | Schematic representation of the phospholipase plate assay
for the identification of quorum sensing inhibitor (QSI) activity. In this
test, 18 h cultures are grown either in the presence or absence of QSI, the
supernatants harvested and sterile ﬁltered, and then added to the punch
holes made in the phospholipid plate. Following an additional 18 h
incubation period, the plates are exposed to UV irradiation and
photographed. The orange halos indicate the lytic activity of untreated
supernatants. Supernatants from QSI-treated cultures would exhibit limited
to no lytic effects and no orange halo.
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FIGURE 3 | Schematic representation of the X-GAL agar plate test,
which can be used in QSI screening efforts of either individual
compounds or more complex natural product extracts. QSIs are
identiﬁed by presence of both a white ring in the hla::lacZ plate and blue
ring on the spa::lacZ plate. (A) hla::lacZ plate: following incubation of the
plate containing the hla reporter, a white clearing surrounding the hole
punch containing the QSI candidate indicates reduced expression of hla
(α-toxin). (B) spa::lacZ plate: following incubation of the plate containing the
spa reporter, a blue zone surrounding the hole punch containing the QSI
candidate indicates increased expression of spa (Protein A).
CELL CULTURE AND EX VIVO TECHNIQUES
Bacterial survival with neutrophils
In this technique, the viability of S. aureus expressing super-
folder green ﬂuorescent protein (sGFP) in the presence of human
neutrophils is assessed by ﬂow cytometry. Following phagocyto-
sis, ﬂuorescence of S. aureus containing neutrophils is measured
as a marker for cell viability (Schwartz et al., 2009; Pang et al.,
2010; White et al., 2014). If the QSI candidate successfully blocks
agr system function, then the impacted S. aureus cells will not
be able to release toxins to damage the neutrophils. In turn,
the S. aureus cells would be left susceptible to neutrophil attack
resulting in a loss of sGFP signal. Toxins under agr regulatory
control have been linked to intracellular survival phenotypes
(Wang et al., 2007). The challenge is that this assay is not par-
ticularly well suited for screening studies of a large chemical
library. It is not known whether an exogenously added compound
could impact the agr regulatory activity following phagocyto-
sis. However, if the technical details on the experiment could be
developed, it might offer insight into the efﬁcacy of speciﬁc com-
pounds in blocking agr-regulated virulence pathways responsible
for neutrophil lysis.
Cytotoxicity testing with S. aureus supernatants
Supernatants harvested from S. aureus cultures grown in the pres-
ence (or absence) of QSI candidates can be examined for the
presence of secreted virulence factors that cause serious dam-
age, and even lysis, of human cells. The following two assays
make use of the lactate dehydrogenase release (LDH) cytotoxic-
ity assay to measure the impact of sterile-ﬁltered supernatants on
the structural integrity of human cell lines. In addition to LDH
tests, useful image data can also be collected of the cells follow-
ing exposure to treated and untreated supernatants with the aid
of ﬂuorescent stains (e.g., LIVE/DEAD or DAPI) and ﬂuorescent
microscopy.
Human neutrophil lysis test. This assay examines the ability of
QSIs to quench the agr pathway to a degree that prevents pro-
duction of virulence factors responsible for neutrophil lysis. PSMs
have been identiﬁed as the main lytic agents in this process (DeLeo
et al., 2009; Pang et al., 2010; Surewaard et al., 2013; Cheung et al.,
2014). Brieﬂy, cultures of agr-active strains are grown in the
presence (and absence) of the QSI under investigation. Human
neutrophils are then exposed to the sterile ﬁltered supernatants,
and lysis is examined using the LDH cytotoxicity test (Nielsen
et al., 2014). If the QSI candidate is, indeed, blocking produc-
tion of virulence factors, the LDH output for neutrophils exposed
to the QSI-treated supernatant will not show statistically signiﬁ-
cant difference from the spontaneous control neutrophils (which
have not been exposed to any supernatant, but just sterile growth
media).
Human keratinocyte cell lysis test. This assay examines the impact
of QSI candidates on toxin production and viability of human ker-
atinocyte (HaCat) cells. Here, S. aureus is grown in the presence of
the QSI candidate or vehicle control, and the supernatant is har-
vested and sterile ﬁltered prior to exposing to HaCat cells. Similar
to the human neutrophil lysis test, this assay uses an LDH kit to
detect cell lysis following exposure to the toxin-containing super-
natant (Cech et al., 2012). Successful QSI candidates will exhibit
no HaCat lysis above that exhibited by the media control.
Rabbit blood cell lysis test
Rabbit erythrocytes prepared from deﬁbrinated blood are exposed
to the supernatants of S. aureus treated with the QSI candidate or
vehicle control. Following a period of incubation at room tem-
perature, the degree of lysis is quantiﬁed by loss of turbidity [as
measured by a plate reader at an optical density (OD) of 630 nm].
This test is a usefulmeasure of agr function as it evaluates the pres-
ence of hemolysins in the supernatant, representing downstream
translational products of RNAIII (Pang et al., 2010). The presence
of hemolysins in the supernatant is conﬁrmed by loss of red blood
cell turbidity, and thus successful QSI candidates will demonstrate
no change in turbidity from the media control. Alternatively, the
change in release of hemoglobin from the lysed red blood cells can
be monitored.
Virulence expression on reconstituted human epithelia
A new in vitro infection model uses reconstituted human epithe-
lium (RHE) for assessing the expression of virulence genes. Here,
S. aureus is grown on the RHE surface, and following a period of
incubation, bacteria are harvested for RNA puriﬁcation, reverse
transcription, and subjected to real-time polymerase chain reac-
tion (RT-PCR) using primers (e.g., spa, cna, and agr) for virulence
gene proﬁling (Paniagua-Contreras et al., 2014). Although origi-
nally developed as a method to compare the proﬁles of a collection
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of clinical isolates, this method could provide interesting insight
into the activity and mechanism of action of QSI lead com-
pounds with regards to agr mediated virulence in an infection
model.
CHROMATOGRAPHIC TOOLS
Quantiﬁcation of δ-hemolysin
Staphylococcal toxins represent downstream products of RNAIII,
and their detection and quantiﬁcation is a useful marker for
assessing agr activity. High performance liquid chromatogra-
phy (HPLC) has emerged a useful tool in medium-throughput
small molecule activity screening efforts. For example, a method
for detecting δ-hemolysin in supernatant by RP-HPLC (Otto
and Gotz, 2000) was modiﬁed to screen a library of medici-
nal plant extracts for QSI natural products (Quave et al., 2011).
The advantages of this system over Western blots for detection of
δ-hemolysin in drug screening efforts is the medium-throughput
nature of the test (if the HPLC is equipped with an autosampler),
highly reproducible quantiﬁcation of the individual formylated
and deformylated δ-hemolysin peaks, and limited sample prepa-
ration requirements as the supernatant can be injected directly
onto the HPLC column. This technique is especially useful for
determination of dose-response trends of a QSI, in which either
the sum of total peak area or total peak height of the formu-
lated and deformylated δ-hemolysin can be measured and plotted
(Figure 4).
In addition to HPLC, mass spectrometry (MS) methods,
including liquid chromatography MS (LC-MS; Somerville et al.,
2003) and Whole Cell Matrix Assisted Laser Desorption Ioniza-
tion Time-of-Flight/Time-of-Flight MS (MALDI-TOF/TOF MS;
Gagnaire et al., 2012) have also been successfully used to detect
δ-hemolysin. TheseMSmethods couldprove veryuseful if adapted
for medium-throughput QSI screening efforts.
FIGURE 4 | High performance liquid chromatography chromatogram of
deformylated and formylated δ-hemolysin present in a USA500
(NRS385) S. aureus culture supernatant. Quantiﬁcation of either the total
peak height or peak area allows for accurate quantiﬁcation of δ-hemolysin
production in cultures grown in the presence (or absence) of QSIs. This
technique is also very useful in dose-dependent activity studies on QSIs.
Quantiﬁcation of PSM-α
As discussed above, agr-regulated PSMs are very effective at
recruiting, activating and lysing human neutrophils, and as such,
they are key to the pathogenesis of S. aureus infections (Otto,
2010). Similar to the detection and quantiﬁcation of δ-hemolysin,
anRP-HPLCmethodhas also beenused to detect the deformylated
and formylated forms of PSM-α in culture supernatants (Chua
et al., 2014). Moreover, new imaging MS (IMS) methods have
been developed to characterize the microbial metabolic output of
strains (including PSMs), which can also be further characterized
by MALDI-MS/MS (Gonzalez et al., 2012).
Quantiﬁcation of extracellular AIPs
Among known S. aureus strains, there are four different classes of
agr systems, each recognizing a unique AIP structure (referred to
as agr-I, agr-II, agr-III, and agr-IV, and correspondingly their cog-
nate signals are termedAIP-I throughAIP-IV). Interestingly, these
different classes of AIPs exhibit cross-inhibition to one another,
and some studies have focused on screening synthetic AIP mimet-
ics (Tal-Gan et al., 2013). Quantitative methods have recently
emerged for analyzing AIP-I (Junio et al., 2013) and AIP-III (Roux
et al., 2014) using ultrahigh performance liquid chromatography
(UHPLC) coupled to electrospray ionization MS with an LTQ
Orbitrap mass spectrometer. This technique is particularly use-
ful in monitoring time-dependent release of AIPs and could be
adapted for assessment of QSI candidate impact on AIP release to
the extracellular environment.
MOLECULAR TOOLS FOR IDENTIFYING QSI
Transcript analysis
One of the original approaches to assessing S. aureus quorum
sensing is through direct analysis of transcripts. Northern anal-
ysis is the classical approach and the high expression level of
rnaIII transcript and its stability make it a useful candidate for
tracking. More recently, quantitative reverse transcriptase PCR
(qRT-PCR) has become a standard alternative approach used by
many laboratories.
Transcriptional analyses by Northern blotting. Probes directed
at RNAIII transcript can be used to assess agr activity (Kjaerulff
et al., 2013). For example, in a study byNielsen et al. (2014), strains
were grown in the presence of a QSI lead molecule, RNA was
puriﬁed, and Northern blot analysis on agrA and psmα was per-
formed. Likewise, in another study on QSI candidates, CA-MRSA
isolates were grown in the presence of solonamides and Northerns
were performed on rnaIII, spa, and hla transcripts to assess dif-
ferences in virulence gene expression between the treated samples
and vehicle control (Mansson et al., 2011). While this technique
is not amenable to large compound screens, it can provide useful
information on the impact of a lead QSI candidate on virulence
gene transcription.
qRT-PCR. Quantitative reverse transcriptase PCR (qRT-PCR)
with primers for agr can be used to monitor agr function (Park
et al., 2007). The best targets for assessment are rnaIII, psmα,
and psmβ transcripts because these are under direct AgrA con-
trol (Queck et al., 2008). As indicated above, Protein A (spa) is also
informative due to its opposite response when agr is inhibited.
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Although the hla transcript, encoding α-toxin, is a popular choice
for an assessment of agr function, its interpretation is more difﬁ-
cult. Thepredominant actionof the agr system is to control protein
translation of Hla. In other words, an agr mutant does not pro-
duce Hla protein, but this mutant will show only minimal changes
(typically twofold) to hla transcript levels. Thus, small molecule
inhibitors that greatly reduce hla transcription should be viewed
with caution since the dominant transcriptional regulator of this
gene is the SaeR/S system (Flack et al., 2014).
Reporter tools
As an alternative to direct analysis of transcripts, transcriptional
reporters for S. aureus quorum sensing dependent promoters are
often used for monitoring agr system function and identifying
QSI. The agr P3 promoter is most commonly used for this pur-
pose due its strong output and large dynamic range. In this section,
different reporter-based approaches are outlined using both ﬂu-
orescent and luminescent markers, and these approaches can be
applied for monitoring agr system function or identifying a QSI.
Fluorescent reporters. A number of ﬂuorescent reporter strains
have been developed for use in studies aimed at understand-
ing the mechanistic underpinnings of the system and for small
molecule QSI screening efforts (Malone et al., 2009; Shojima and
Nakayama, 2014). The most commonly used ones contain either
a GFP, or a similar emitting yellow ﬂuorescent protein (YFP), that
is linked to the agr P3 promoter. Although the agr P2 promoter
has been utilized, it has much weaker output and a more lim-
ited dynamic range. When these reporters are used in conjunction
with a microplate reader that has the capacity for reading OD
for growth and ﬂuorescence, these strains allow for the detection
of either promotion or inhibition of the agr system. Moreover,
these tools are readily adaptable for high-throughput screening
of small molecule repositories. For example, a screen of a 24,087
compound library using a reporter strain with agr::P3 driven GFP
expression resulted in the discovery of savirin as a small molecule
inhibitor of AgrA, which was further supported by additional in
vitro and in vivo studies (Sully et al., 2014). Successful QSI candi-
dates exhibit growth ODs similar to those of the vehicle control,
but with signiﬁcantly reduced ﬂuorescence outputs, signaling loss
of agr P3 promoter activation.
BlaZ reporter. The agr P3-blaZ reporter has been used in some of
the original efforts to identify S. aureus QSI (Mayville et al., 1999;
Lyon et al., 2000). The blaZ gene encodes for β-lactamase, and
the activity of BlaZ enzyme can be easily tracked using nitroceﬁn
assays. The technique is also useful for mechanistic investigations
of agr system function (Geisinger et al., 2012). Recently, the BlaZ
reporter has been used in efforts to characterize the natural prod-
uct solonamide B as an AgrC antagonist (Nielsen et al., 2014). The
reporter could be used to identify agr inhibitors in the medium
throughput screening models described above.
AIP competition assay. Autoinducing peptide competition can
also be tracked through the use of ﬂuorescent reporters (see
section Fluorescent reporters) for the different agr and AIP types
(Malone et al., 2007). Reporter strains are grown in the presence
of the appropriate antibiotic to maintain the plasmid, and then
once reaching an established OD, are aliquotted and mixed with
either control media or competing AIP. Cell density and ﬂuores-
cence is measured with a microplate reader to examine impact
on growth and agr activity. A decline in ﬂuorescence, without
impacting growth, is interpreted as QSI activity. This approach
was successfully used to test Type I signal peptidase inhibitors for
impact on agr function (Kavanaugh et al., 2007), and it could be
amenable to screening compound libraries.
Vesicle lysis test. A new method to detect small amphipathic
α-helical peptides and measure agr activity has been developed
(Laabei et al., 2014). The synthetic lipid vesicle type used in
this assay was chosen speciﬁcally for its selectivity to PSMs and
δ-hemolysin, excluding other known S. aureus toxins. The vesi-
cles prepared for this test comprise a similar level of cholesterol
as that found in erythrocytes (20–25%) and includes two very
common membrane phosphoglycerides: phosphatidylcholine and
phosphatidylethanolamine. Following preparation of the vesicles,
bacteria can either be normalized to a speciﬁc OD for correspond-
ing colony forming units per mL (CFUs/mL) or supernatants
can be harvested for use in the experiment. The vesicle solution
and bacteria (or supernatant) are then mixed and ﬂuorescence is
monitored with a ﬂuorescent detector. An increase in normalized
ﬂuorescence over the untreated control (with no toxin) indicates
an increase in toxin-mediated vesicle lysis. Some advantages of this
assay include that it is relatively quick to perform and is amenable
to 96-well plate medium throughput testing using a plate reader
with ﬂuorescent detection abilities. It is reported to have greater
accuracy in correctly identifying strains with active agr systems
than the CAMP assay (Laabei et al., 2014). It could be adapted
to QSI screening efforts perhaps either by inclusion of QSI can-
didates in the test containing live, OD-standardized culture or
by using supernatants of cultures grown in the presence of QSI
candidates.
Luminescent reporters. Strains with lux reporters that link the
agr system to a bioluminescence response have been developed
(Park et al., 2007; Subrt et al., 2011; Figueroa et al., 2014). These
constructs utilize thePhotorhabdus luminescens luxCDABCE genes
that self-produce light without the need for additives. Since the
lux genes are often poorly expressed in Gram-positive bacteria
such as S. aureus, improved constructs have been developed that
increase production of the fatty acid aldehyde substrate needed
(Mesak et al., 2009). The agr P3 promoter has been coupled to
this improved construct for tracking quorum sensing function
(Subrt et al., 2011). Recently, this construct has been moved to
clinical isolates and used successfully to screen for QSIs (Figueroa
et al., 2014). As described above for ﬂuorescent reporter screens,
in comparison with the vehicle control, successful QSI candidates
yield little to no change to growth OD but signiﬁcant reduction in
luminescent output.
CONCLUSION
At a time when the ﬁeld of medicine stands on the precipice
of the post-antibiotic era (CDC, 2013), the anti-virulence strat-
egy may represent a viable solution to addressing the emerging
therapeutic gaps presented by growing trends in antibiotic resis-
tance (Spellberg et al., 2013). This strategy aims to interfere with
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cell–cell communication, or quorum sensing, through which
single-celled organisms coordinate gene expression in adaptive
measures to enhance survival in their respective environments,
including their human hosts. Discovery of small molecule QSI
candidates represents the ﬁrst step in the path toward integration
of an anti-virulence strategy into the treatment and management
of S. aureus infections.
Over the past decade, the “toolbox” for studying the S. aureus
agr QS system and searching for novel QSI candidates has
expanded greatly. In addition to the standard, lower throughput
Western andNorthern blots,wenowhave a suite of ﬂuorescent and
luminescent reporter strains as well as various chromatographic
techniques at our disposal for the study of this important viru-
lence target. Nevertheless, most of these techniques have not yet
been further developed or modiﬁed for applications in medium-
to high-throughput screening efforts for the identiﬁcation of novel
QSIs. One caveat concerning studies focused on agr as a tar-
get is the potential impact of test candidates on growth. This is
something that must be closely monitored as growth-dependent
inhibition can yield a false-positive result for QSI activity, and
thus QSI activity should be explored at sub-MIC concentrations.
Likewise, QSIs inhibiting certain virulence factors (i.e., α-toxin)
require additional evaluation, as this may not reﬂect true agr inhi-
bition, but rather alternative (or additional) impact on the S.
aureus SaeR/S system. Future work should build on these existing
resources, optimizing them to further support efforts for the iden-
tiﬁcation and mechanistic analysis of small molecule inhibitors of
this highly clinically relevant target.
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